With QUiCKR, file IND 10 months sooner and save 30%
Lead Optimization
360 Days
70 Days
Testing Cost
$500,000
$350,000
Faster to market, earlier therapy sales
+30%
QUiCKR V2
20 min sample-to-results
High-Throughput
Automated
0 new instruments required
30,000+ reactions analyzed to date
QUiCKR Workflow
Quantification Using initial CRISPR Kinetic Rates
Edited Sample
Sample Prep
Plate Transfer
Fluorescent
Readout
Cloud-based
Instant Results
Meet Our Team
We are passionate about accelerating broad access to life saving genetic medicines. Our mission is to engineer tools that test genetic modifications instantaneously. Imagine a world where genetic engineering can iterate as fast as software engineering.
Charles Blanluet
CEO & Cofounder
Stanford Microfludics, Guardant
Prof. Juan Santiago
Scientific Cofounder
Stanford Microfludics, Purigen Biosystems
Jiawei Lee
CBO & Cofounder
UC Berkeley & UCSF, Sequoia
Henrik Sperber
CTO & Cofounder
CRISPR Therapeutics, Paratus Sciences
Prof. Matthew Porteus
Scientific Advisor
Stanford Medicine, CRISPR Therapeutics
Hari Jayaram
Scientific Advisor
Verve Therapeutics, Editas Medicine, Arena BioWorks
Sepehr Kiani